Young Women’s Advocate Now to Grow, Empower and Lead (ANGEL) Advocacy Training

ANGEL Advocacy Program

The Tigerlily Foundation is committed to mobilizing our community of young women, caregivers, and loved ones to transform lives and recognize that we must Advocate Now to Grow, Empower & Lead through the ANGEL Advocacy Program. The ANGEL Advocacy Program has two foundational initiatives to mobilize this community:

The ANGEL Advocacy Program provides comprehensive training for women of color between the ages of 21  and 50, who have been impacted by breast cancer, either by being diagnosed themselves or who have had a loved one touched by the disease.

In the U.S., breast cancer is the most commonly diagnosed cancer in women in their 20s and 30s, and Black women are diagnosed at younger ages and with more aggressive types of breast cancer than any other group. Through this program, advocates become more knowledgeable about breast cancer, and the disparities that affect this population, they also become empowered to create change, learn how to become better self-advocates, and advocate on behalf of individuals and their greater community to make system-wide impacts.

Our ANGEL Advocates use their time and voices to make an impact by speaking at events, being showcased in the media, advocating with policymakers, speaking on panels, sharing information on breast health and advocacy through their social media channels and engaging healthcare professionals. Many ANGEL Advocates are directly involved with developing our programs and partnering with research and scientific communities to ensure clinical trials, studies, programs and content are relevant to their population. 

Our ANGEL Advocates are making a powerful impact in our breast cancer communities, locally, nationally and globally. 

Currently Accepting Applications for the ANGEL Advocacy Program

We are currently accepting applications from women between the ages of 21 to 50, who have been impacted by breast cancer to participate in the upcoming ANGEL Advocacy Program training cohort.

With a focus on ending breast cancer disparities largely impacting the Black community, we are currently conducting targeted outreach to this community and strongly encouraging young Black women in the following areas to apply to become a Tigerlily ANGEL Advocate:

  • California: Alameda County
  • Pennsylvania: Philadelphia County
  • District of Columbia: Washington, D.C.
  • Louisiana: Orleans Parish County
  • Michigan: Oakland County

Katrece Nolen

Survivor of Stage III Inflammatory Breast Cancer, Diagnosed at Age 38

Our ANGELS are at the forefront of the  charge to transform the outcomes for Black women and how they are educated and represented within the patient, policymaking, provider, research and scientific communities.  We work with patients and stakeholders in the cities with the highest breast cancer death rates for Black women.  Join us in working to change outcomes for Black women and achieve health equity in our lifetime.

Interested in becoming a Tigerlily ANGEL? Let’s get in touch. e-mail TLFANGEL@tigerlilyfoundation.org

Advocacy Posters

Tigerlily is excited to roll out ANGEL Advocacy Cohorts

ADVOCACY IN ACTION
BMS is supporting activity in 5 cities with high disparities.

BMS is supporting activity in 5 cities with high disparities.

DIVERSITY IN CLINICAL TRIALS
Eli_Lilly_and_Company.svg
1200px-Amgen.svg
merck-logo-png-5
1200px-Sanofi.svg (1)
daiichi_cover
SeaGen_Intl
PRACTICE TO POLICY
Collaborating with patients to ensure best practices

Collaborating with patients to ensure best practices

WHERE SCIENCE MEETS SOUL
Collaborating with patients to ensure that the heart of the communities facing disparities is integrated into the science of clinical trial development

Collaborating with patients to ensure that the heart of the communities facing disparities is integrated into the science of clinical trial development

ANGEL PATIENT COMMUNITY & PATIENT MENTORS
Puma-Biotechnology-Logo_on_transparent_background

Supported By

bms_foundation_stacked_300_pos
Amgen
merck-logo-png-5
Print
Sanofi
Daiichi-Sankyo
SeaGen_Intl

Leave Comment

Your email address will not be published. Required fields are marked *